(Press-News.org) DALLAS – Feb. 6, 2012 – An endocrine hormone used in clinical trials as an anti-obesity and anti-diabetes drug causes significant and rapid bone loss in mice, raising concerns about its safe use, UT Southwestern Medical Center researchers have shown.
The hormone, fibroblast growth factor 21 (FGF21), promotes bone loss by enhancing the activity of a protein that stimulates fat cells but inhibits bone cells, researchers report in a study available online in Proceedings of the National Academy of Sciences.
“This hormone is a very potent regulator of bone mass,” said Dr. Yihong Wan, assistant professor of pharmacology and senior author of the study. “When we oversupply FGF21 in mice, it results in substantial bone loss.”
UT Southwestern scientists had been investigating this hormone’s properties since its discovery in 2005 as a potential drug. Bone loss was a side effect of another class of compounds that had been commonly used in the treatment of diabetes – activating the same protein in a manner similar to FGF21 – and leading the research team to investigate the bone effect of FGF21 in three kinds of mice.
They found that rodents fed a drug form of the hormone over a two-week period lost 78 percent of their spongy bone. Mice engineered to produce excess FGF21 had similar effects. Conversely, researchers found mice completely lacking the hormone had comparable gains in bone mass.
While the insulin-sensitizing effects of FGF21 make it a potentially powerful anti-obesity drug, that could be canceled out by risk of osteoporosis and fractures associated with bone loss, the investigators report.
“The bone effect is clear,” said Dr. David Mangelsdorf, chairman of pharmacology, a Howard Hughes Medical Institute investigator at UT Southwestern and one of the study’s corresponding authors. “It’s a tradeoff of benefits and risks, and the key will be to design the drug in such a way to leverage the two against each other, dialing out the side effects and dialing in the positive.”
In a related study online in Cell, researchers at the medical center identified how FGF21 regulates the activity of a diabetes-fighting compound in fat tissue, altering metabolism in response to starvation and resumed eating for survival-driven energy conservation.
“FGF21 helps mobilize the fat in adipose tissue back to the liver and burn it. But when the animal is refed, it stops this process and immediately turns back to restoring fat. In one case, it turns this system on, and in the other, turns it off,” said Dr. Steven Kliewer, professor of molecular biology and pharmacology and senior author of the Cell paper.
UT Southwestern researchers involved in the PNAS study were Dr. Wei Wei, lead author and postdoctoral researcher in pharmacology; Dr. Paul Dutchak, postdoctoral researcher in neuroscience; Drs. Xunde Wang and Xushan Ding, postdoctoral researchers in pharmacology; Dr. Xueqian Wang, research associate in pharmacology; Angie Bookout, graduate student in internal medicine; Dr. Robert Gerard, associate professor of internal medicine; and Dr. Kliewer.
The scientists in the Cell study included Dr. Dutchak, lead author involved while a graduate student in pharmacology; Takeshi Katafuchi, instructor in pharmacology; Ms. Bookout; and Dr. Mangelsdorf.
INFORMATION:
Support for the studies came from the Cancer Prevention and Research Institute of Texas, March of Dimes, Robert A. Welch Foundation, National Institutes of Health and the HHMI.
Visit www.utsouthwestern.org/endocrinology to learn more about UT Southwestern’s clinical services in endocrinology, including diabetes.
This news release is available on our World Wide Web home page at
www.utsouthwestern.edu/home/news/index.html
To automatically receive news releases from UT Southwestern via e-mail,
subscribe at www.utsouthwestern.edu/receivenews
Study: Rapid bone loss as possible side effect of anti-obesity drug now in clinical trials
2012-02-08
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
New Dating Site for Those Who Want to Have a Baby, to Find a Co-Parent in the USA
2012-02-08
This pioneering and remarkable community was created in 2008 in France to provide these people the chance to meet others of a similar mindset, who want a baby independently.
Coparents.com has a comprehensive range of search options allows people to find the favoured person you require. Whether an individual or couple are looking for a co-parent, sperm donor or a surrogate mother, Coparents.com connects those who wish to have a baby, but haven't found the right person yet.
The wonderful thing about Coparents.com is that it provides everyone who can't have a child ...
A team of CRCHUM researchers paves the way for improving treatment for Type 2 diabetes
2012-02-08
Montreal (Canada), February 6, 2012 – In a study published last week in the prestigious Proceedings of the National Academy of Sciences of the United States of America, a team led by Dr. Vincent Poitout of the University of Montreal Hospital Research Centre (CRCHUM)* has made an important step forward in understanding how insulin secretion is regulated in the body. This discovery has important implications for drugs currently in development to treat Type 2 diabetes, a disease which is diagnosed every 10 seconds somewhere throughout the world.
Poitout's team studies the ...
New DVT guidelines: No evidence to support 'economy class syndrome'
2012-02-08
New evidence-based guidelines from the American College of Chest Physicians (ACCP) address the many risk factors for developing a deep vein thrombosis (DVT), or blood clot, as the result of long-distance travel. These risk factors include the use of oral contraceptives, sitting in a window seat, advanced age, and pregnancy. The Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, published in the February issue of the journal CHEST, also suggest there is no definitive evidence to support ...
The Lancashire Hotspot - Locals are Luckiest in Halifax Prize Draw
2012-02-08
Savers in the Lancashire area have established themselves as the luckiest in the country as another 79 entrants into the Halifax Savers Prize Draw picked up a prize this month. A total of GBP10,600 is heading into the county in prizes this month, bringing the total amount Lancashire savers have won in the draw to GBP26,100 in just two months. A total of 153 local savers have won a prize of GBP100 or GBP1000 in the December and January draws.
With over 560,000 registrations, the unique Halifax Savers Prize Draw has grown even further in popularity with UK savers in January. ...
Not the black sheep of domestic animals
2012-02-08
Mapping the ancestry of sheep over the past 11,000 years has revealed that our woolly friends are stars among domestic animals, boasting vast genetic diversity and substantial prospects for continued breeding to further boost wool and food production for a rising world population.
An international research team has provided an unprecedented in-depth view of the genetic history of sheep, one of the world's most important livestock species. The study, published February 7 in the online, open-access journal PLoS Biology, maps out how humans have moulded sheep to suit diverse ...
New guidelines suggest DVT prophylaxis not appropriate for all patients
2012-02-08
New evidence-based guidelines from the American College of Chest Physicians (ACCP) recommend considering individual patients' risk of thrombosis when deciding for or against the use of preventive therapies for deep vein thrombosis (DVT) and venous thromboembolism (VTE). Specifically, the Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, published in the February issue of the journal CHEST, focus on risk stratification of patients, suggesting clinicians should consider a patient's ...
Brain mechanisms link foods to rising obesity rates
2012-02-08
CINCINNATI—An editorial authored by University of Cincinnati (UC) diabetes researchers to be published in the Feb. 7, 2012, issue of the journal Cell Metabolism sheds light on the biological factors contributing to rising rates of obesity and discusses strategies to reduce body weight.
According to the U.S. Centers for Disease Control, about one-third of U.S. adults are obese, a number that continues to climb.
"While we don't usually think of it this way, body weight is regulated. How much we weigh is influenced by a number of biological systems, and this is part ...
Metabolic profiles essential for personalizing cancer therapy
2012-02-08
One way to tackle a tumor is to take aim at the metabolic reactions that fuel their growth. But a report in the February Cell Metabolism, a Cell Press Publication, shows that one metabolism-targeted cancer therapy will not fit all. That means that metabolic profiling will be essential for defining each cancer and choosing the best treatment accordingly, the researchers say.
The evidence comes from studies in mice showing that tumors' metabolic profiles vary based on the genes underlying a particular cancer and on the tissue of origin.
"Cancer research is dominated now ...
Transmission of Clostridium difficile in hospitals may not be through contact with infected patients
2012-02-08
Contrary to current convention by which infection with the organism Clostridium difficile is regarded as an infection that is acquired by contact with symptomatic patients known to be infected with C. difficile, these may account for only a minority of new cases of the infection. These findings are important as they indicate that C. difficile infection, which can be fatal especially in older people, may not be effectively controlled by current hospital infection strategies.
In a study led by Professor Tim Peto of the John Radcliffe Hospital in Oxford, UK, and published ...
Mild cognitive impairment is associated with disability and neuropsychiatric symptoms
2012-02-08
In low- and middle-income countries, mild cognitive impairment—an intermediate state between normal signs of cognitive aging, such as becoming increasingly forgetful, and dementia, which may or may not progress—is consistently associated with higher disability and with neuropsychiatric symptoms but not with most socio-demographic factors, according to a large study published in this week's PLoS Medicine.
The established 10/66 Dementia Research Group interviewed approximately 15 000 people over 65 years of age who did not have dementia in eight low- and middle-incomes ...